Fed Regist. 2013 Sep 24;78(185):58785-828.
The Food and Drug Administration (FDA) is issuing a final rule to establish a system to adequately identify devices through distribution and use. This rule requires the label of medical devices to include a unique device identifier (UDI), except where the rule provides for an exception or alternative placement. The labeler must submit product information concerning devices to FDA's Global Unique Device Identification Database (GUDID), unless subject to an exception or alternative. The system established by this rule requires the label and device package of each medical device to include a UDI and requires that each UDI be provided in a plain-text version and in a form that uses automatic identification and data capture (AIDC) technology. The UDI will be required to be directly marked on the device itself if the device is intended to be used more than once and intended to be reprocessed before each use.
美国食品药品监督管理局(FDA)正在发布一项最终规则,以建立一个在医疗器械的流通和使用过程中对其进行充分标识的系统。本规则要求医疗器械的标签包含唯一器械标识(UDI),但本规则规定有例外情况或可采用其他放置方式的除外。标签商必须向FDA的全球唯一器械标识数据库(GUDID)提交有关器械的产品信息,除非符合例外情况或采用其他方式。本规则建立的系统要求每个医疗器械的标签和器械包装都包含一个UDI,并要求每个UDI都以纯文本形式以及使用自动识别和数据采集(AIDC)技术的形式提供。如果器械预期会被多次使用且每次使用前都要进行再处理,则要求将UDI直接标记在器械本身上。